Altimmune, Inc. (ALT)
NASDAQ: ALT · IEX Real-Time Price · USD
6.75
+0.06 (0.90%)
At close: Jul 26, 2024, 4:00 PM
6.78
+0.03 (0.44%)
After-hours: Jul 26, 2024, 7:13 PM EDT

Altimmune Market Cap

Altimmune has a market cap or net worth of $478.59 million as of July 26, 2024. Its market cap has increased by 192.36% in one year.

Market Cap
478.59M
Enterprise Value
296.52M
1-Year Change
192.36%
Ranking
Category
Stock Price
$6.75

Market Cap Chart

Since October 6, 2005, Altimmune's market cap has increased from $81.50M to $478.59M, an increase of 487.23%. That is a compound annual growth rate of 9.87%.

History

DateMarket Cap% Change
Jul 25, 2024474.30M-21.53%
Dec 29, 2023604.40M-25.26%
Dec 30, 2022808.70M122.17%
Dec 31, 2021364.00M-2.41%
Dec 31, 2020373.00M1,186.21%
Dec 31, 201929.00M61.11%
Dec 31, 201818.00M-42.12%
Dec 29, 201731.10M-85.66%
Dec 30, 2016216.90M77.06%
Dec 31, 2015122.50M6.80%
Dec 31, 2014114.70M17.88%
Dec 31, 201397.30M79.52%
Dec 31, 201254.20M-11.58%
Dec 30, 201161.30M-64.57%
Dec 31, 2010173.00M210.59%
Dec 31, 200955.70M-6.39%
Dec 31, 200859.50M-31.77%
Dec 31, 200787.20M1.04%
Dec 29, 200686.30M4.10%
Dec 30, 200582.90M1.72%
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Nkarta 468.61M
MaxCyte 466.27M
Editas Medicine 464.23M
Nano-X Imaging 461.37M
Korro Bio 459.75M
Taysha Gene Therapies 452.10M
Health Catalyst 451.62M
Sonida Senior Living 446.45M
Market Cap Rankings